Lyell Immunopharma Inc (LYEL) — Working Capital to Net Assets Ratio
Lyell Immunopharma Inc (LYEL) has a Working Capital to Net Assets ratio of 85.2% as of December 2025. Working capital of $211.53 Million (current assets of $260.94 Million minus current liabilities of $49.41 Million) is measured against net assets of $248.20 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Lyell Immunopharma Inc to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Lyell Immunopharma Inc Working Capital to Net Assets (2019–2025)
This chart shows how Lyell Immunopharma Inc's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the ratio stands at 85.2%, reflecting working capital of $211.53 Million against net assets of $248.20 Million USD. For the complete balance sheet picture, see LYEL total assets.
Annual Working Capital to Net Assets for Lyell Immunopharma Inc (2019–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Lyell Immunopharma Inc from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Lyell Immunopharma Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 85.2% | $211.53 Million | $248.20 Million | $260.94 Million | $49.41 Million | ▲ +0.1 pp |
| 2024 | 85.1% | $325.81 Million | $382.82 Million | $379.59 Million | $53.79 Million | ▲ +5.7 pp |
| 2023 | 79.4% | $520.17 Million | $654.95 Million | $554.69 Million | $34.52 Million | ▲ +5.7 pp |
| 2022 | 73.7% | $614.27 Million | $833.25 Million | $651.29 Million | $37.03 Million | ▲ +11.4 pp |
| 2021 | 62.3% | $579.55 Million | $929.79 Million | $626.29 Million | $46.74 Million | ▼ -16.8 pp |
| 2020 | 79.1% | $568.26 Million | $718.44 Million | $617.55 Million | $49.28 Million | ▼ -23.4 pp |
| 2019 | 102.5% | $418.21 Million | $408.06 Million | $440.26 Million | $22.05 Million | — |